Journal profile

Novartis Foundation symposium

ISSN 1528-2511 · eISSN 1935-4657 · Irregular

Novartis Foundation symposium: subscription journal; review about 1 month (community reports); community-reported acceptance: about 95%; 0 articles in 2025.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review timeabout 1 monthCommunity average
APC—No source gives fee information
Acceptanceabout 95%Community average
Articles per year02025 · OpenAlex count

Scope

Aims, scope and focus

By OpenAlex counts of its recent articles, Novartis Foundation symposium's largest topics are Neuroscience and Neuropharmacology Research, Developmental Biology and Gene Regulation and T-cell and B-cell Immunology, together about 22.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results.

From the journal's Aims & Scope

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Neuroscience and Neuropharmacology ResearchNeuroscience8.2%
  2. Developmental Biology and Gene RegulationBiochemistry, Genetics and Molecular Biology7.2%
  3. T-cell and B-cell ImmunologyImmunology and Microbiology7.1%
  4. Adrenal Hormones and DisordersMedicine4.7%
  5. Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology4.7%
  6. Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology4.6%
  7. Ion Transport and Channel RegulationBiochemistry, Genetics and Molecular Biology4.5%
  8. Growth Hormone and Insulin-like Growth FactorsMedicine4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

Indexed in: no record yet.

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
123OpenAlex ·
i10-index
3,503OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 9,093 in total · the current year is incomplete

YearArticlesOpen accessCitations
202600640
2025001,432
2024001,942
2023002,005
2022002,036
2021002,315

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 1 monthLetPub ·
Average acceptance (community reports)
95%LetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Subscription journalLetPub

A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Frequency
Irregular
ISSN
1528-2511
Electronic ISSN
1935-4657
Official links

FAQ

Frequently asked questions about Novartis Foundation symposium

How long does peer review take at Novartis Foundation symposium?

Authors report an average review time of about 1 month; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Is Novartis Foundation symposium open access, and what is the APC?

Novartis Foundation symposium is a subscription journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .